Srivastava, Amit http://orcid.org/0000-0002-2510-5058
Dempsey, Amanda
Galitsky, Alex
Fahimi, Mansour
Huang, Liping
Funding for this research was provided by:
Pfizer (N/A)
Article History
Received: 8 October 2019
Accepted: 29 June 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: All participants of the study consented their willingness to participate via email. Their decision for participation was voluntary and could be canceled at any time during the study if they decided not to participate. The study protocol was reviewed and approved by Western Institutional Review Board (WIRB), which is an independent institutional review board (IRB Pr. No.: 20162459; IRB Study No.: 1169549). WIRB found that the research met the requirements for a waiver of documentation of consent under 45 CFR 46.117(c)(2).
: Not applicable.
: AD serves on advisory boards for Merck, Pfizer, and Sanofi Pasteur and as a consultant to Pfizer. AS and LH are employees of Pfizer and may hold stock or stock options. AG and MF are employees of Ipsos, who were paid contractors to Pfizer Inc and conducted the survey.